MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level

Ying Liu, Lin Qi, Bicheng Ye, Anbang Wang, Juan Lu, Le Qu, Peng Luo, Linhui Wang, Aimin Jiang

Open source

DOI
10.1080/15384047.2024.2345977
Published
2024-04-24
Container
Cancer Biology & Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/15384047.2024.2345977,
  title = {MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level},
  author = {Ying Liu and Lin Qi and Bicheng Ye and Anbang Wang and Juan Lu and Le Qu and Peng Luo and Linhui Wang and Aimin Jiang},
  year = {2024},
  journal = {Cancer Biology \& Therapy},
  doi = {10.1080/15384047.2024.2345977},
  url = {https://doi.org/10.1080/15384047.2024.2345977}
}

RIS

TY  - JOUR
TI  - MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level
AU  - Ying Liu
AU  - Lin Qi
AU  - Bicheng Ye
AU  - Anbang Wang
AU  - Juan Lu
AU  - Le Qu
AU  - Peng Luo
AU  - Linhui Wang
AU  - Aimin Jiang
PY  - 2024
JO  - Cancer Biology & Therapy
DO  - 10.1080/15384047.2024.2345977
UR  - https://doi.org/10.1080/15384047.2024.2345977
ER  - 

APA

Liu, Y., Qi, L., Ye, B., Wang, A., Lu, J., Qu, L., Luo, P., Wang, L., & Jiang, A. (2024). MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer Biology & Therapy. https://doi.org/10.1080/15384047.2024.2345977

Source records